Projects

Bioscience Enterprise Thesis Topics

During the final six months of their qualification the MBioEnt student’s undertake a full-time internship with a bioscience company or organisation. During this time they work on a specific project that is of significance and value to the host company. The project also forms the basis of the research for the students’ Masters theses.

Please note - the topics below are intended to illustrate the diversity of topics that have been studied. The list also illustrates the breadth of bioscience addressed – from drug development to clean tech to medical technologies to agbio and functional foods. It is by no means the total list, nor is it meant to in any way define or limit the range of topics that would be suitable. Please use them as examples and inspiration.

2016 Thesis Topics

  • Diffusion of information through complex networks
  • New business models for the pharmaceutical industry
  • Social media as a business tool in emerging markets
  • Mapping the market validation process for biotechnology innovation
  • Internationalisation strategy for early-stage NZ biotechnology companies, with a focus on Asian markets
  • Optimising NZ’s biotechnology sector to encourage growth
  • Industry perspectives on the concept of an online portal for the NZ biotechnology industry
  • Collection and analysis of end-user feedback on a novel technology
  • The Chinese regulatory environment for functional foods
  • How NZ SMEs engage with offshore multinational companies
  • Perception of risk associated with life science start-ups commercialising new technologies
  • Considerations for a NZ biotechnology accelerator
  • The role of knowledge sharing in successful marketing of novel life science technologies
  • Social media use in the nutraceutical sector


2015 Thesis Topics:

  • Mechanisms Technology Transfer Offices use to address the lack of funding for early-stage projects
  • IP strategies across HTM companies
  • Predicting trends in medical devices and technologies
  • Exporting highly perishable fruits to Asia
  • Business models for health IT start-ups
  • Design thinking: a cognition toolbox
  • Barriers to the comercialisation of interdisciplinary research
  • Business models for the successful sale of generic drugs in NZ
  • Shared medical records (doctor-pharmacist) to enhance patient health outcomes
  • Opportunities for antimocrobial-coated dressings
  • Multinationals sourcing innovation from Australia and NZ: drivers and restraints
  • Development considerations for some veterinary medicine products
  • Tech transfer business models for v. early spin-offs owned by multiple parties
  • Alternatives to maintaining an expensive IP portfolio, for NZ high-tech start-ups
  • Luxury health foods markets in China

2014 Thesis Topics:

  • Characterising early stage medical devices in NZ
  • How business angel networks function and meet the early stage
  • Exploring the feasibility of Blue Ocean Strategy as an idea generation and strategy development tool in the nutraceutical industry
  • An exploratory investigation into the decision-making process of investors in NZ
  • Market validation in new-technology development - an exploratory study of NZ start-up companies
  • Global regulatory implications of a novel extraction technology for a NZ nutraceutical company
  • Methodologies and techniques that are used to study mechanism of action of fatty acids in treating atopic dermatitis
  • An assessment of the agricultural applications of basalt rock dust
  • Relocation factors for NZ biotech companies moving offshore
  • The NZ Natural Health and Supplementary Products Bill: A qualitative analysis on industry business response
  • Social media utilisation by assisted reproductive technology clinics in Australasia - roles, risk and benefits
  • Commercialisation strategies for polyphenol-rich products from horticultural co-product streams
  • Commercialisation strategy for the digital healthcare industry
  • Government initiatives to support the success of public research Commercialisation
  • Reducing uncertainty, complexity and ambiguity in concept selection during the front end of the innovation process in forensics
  • The ramifications of a biotech push for the national innovation system of Singapore
  • Patent Trends & Innovation in the Biofuels Industry
  • Genome sequencing in personalised medicine: The development of clinical pathways over the next five years

2013 Thesis topics:

  • Research and Development Portfolio Management in the New Zealand Bioscience Sector: An Industry Practices Study
  • Market Access for High-Value Diagnostics in Sweden and Germany
  • Strategy for biofuel ventures: applying strategic tools to the case of a New Zealand start-up
  • Challenges and strategies for the development and commercialisation of discontinuous and disruptive biotechnology innovations in New Zealand
  • An Unexpected Journey: An Action Research Approach to the Development of a Customer Relationship Management (CRM) Solution in a Clinical Research Organization".
  • Fuzzy Front End Strategy For Disruptive Innovations In The Implantable Medical Device Industry: A New Zealand SME Case Study
  • An exploration of consumer purchase decision making process in the non-prescription eczema space
  • Informing NPD: Investigation into the drivers of perceived value by specialist physicians in new gynaecological surgery devices
  • Like, Comment, Share: Social Media Use in New Zealand Nutritional Companies
  • Factors underlying commercialization of platform technologies in biotechnology
  • Challenges faced by small New Zealand Biotechs during New Product Development: a qualitative study of companies with incremental innovations
  • Commercial Strategy Selection Medical Device Start-ups: Integrate Vs. Cooperate
  • Being local or global: Healthcare firms moving into and within Southeast Asia
  • Partnership Opportunities for the University of Auckland in the Nutraceutical and Functional Food (NFF) Sector
  • Exploring the technology out-licensing options for New Zealand start-ups: A case study of Footfalls and Heartbeats
  • A DHB perspective on capturing clinical trial value in Auckland
  • Investing in Intellectual Property: Early-Stage Investors’ Attitudes Towards Intellectual Property Assets.
  • Pharmacoeconomic considerations for a novel atopic dermatitis therapy
  • Managing Intellectual Property (IP) in open innovation: The facilitating role of research organisations
  • Innovation through design thinking in a nutrition context.

2012 Thesis Topics:

  • Expanding the Business Model of an SME in the Bioscience Sector
  • Perceptions and implications of the NZ Natural Health Products Bill
  • Dynamics of Effectuation and Causation in a Test Case NZ Small and Medium Enterprise
  • The Funding of Innovative Cardiovascular devices in Europe
  • A Comparison of two Composting Systems for the Processing of Source-Separated Organic Waste in New Zealand: A Case Study from a Large-Scale Commercial Composter
  • Navigating through the patent landscape: the legal implications for a biotechnology SME in New Zealand
  • Strategic decision making processes for platform technologies in pharmaceutical SMEs in NZ
  • Bridging cultural gaps between New Zealand life science firms and their Chinese partners
  • Adoption of incremental innovation in healthcare
  • Intellectual property protection and management strategies in New Zealand’s bioenergy sector
  • Growing the Business of Auckland’s Clinical Trials
  • Growth Patterns of Contract Research Organizations
  • Understanding the Barriers to Social Media Adoption by Health Professionals: A multi-country study
  • Investment Strategies of Ahu Whenua Maori Land Trusts
  • The structure of venture capital funds: An exploratory study
  • The effect of integrated gamification within pedometers on increased physical activity
  • Understanding market needs in the New Zealand dairy industry
  • The Economic Risks and Opportunities for New Zealand from Genetically Modified Organisms
  • Quality by Design and its implications in the Generic Pharmaceutical industry.

2011 Thesis Topics:-

  • The Role of Social Media in Strategy for Pharmaceutical Companies
  • The role of peptides in the biotech industry
  • Commercialisation of Health Information Technology
  • A decision making framework for human pharmaceuticals in NZ: building on national strengths while responding to global trends
  • Trends for producing reside-free-crops - where is the fit for biological control products
  • Pricing and reimbursement strategies for life science products
  • Exploring innovative milk compositions/bioactives and analyzing its commercial implications
  • The effect of cultural norms on product, brand and packaging design - a case study of New Zealand added-value dairy products in China
  • Looking at the perception of xenotransplantation in the Asian Market and comparing this to Western markets
  • A valuation model for enzyme technologies
  • Management Succession in Biotechnology Companies
  • How government (i.e. FRST/MSI) investment in biotechnology and clean technology firms is managed to give commercial success
  • New Product Development Portfolio Management
  • Reviewing and analysing the commercialization options for HyACT/antibodies in an oncology context
  • How can a dairy small-medium enterprise collaborate with public/private research groups to commercialise dairy bioactives in the Asian market?
  • Marketing and distribution strategy for pharmaceuticals
  • The Health IT evaluation framework developed by NIHI, A strategic "leveraging" approach to build NIHI's international presence and capture the potential commercial value of the niche evaluation framework in the offshore market
  • Review of current commercialisation pathways for dairy innovation both in New Zealand and globally
  • Challenges and Opportunities for Entrepreneurs for the New Zealand Prosthetics Industry
  • To proceed or not to proceed with a Medical Device Innovation: A decision making framework for technology based SME's.


2010 Thesis Topics:-

  • Understanding the acceptability of a new product within a social system
  • Intellectual property protections of plant varieties in the context of fruits and vegetables: multiple case studies of protection strategies
  • Understanding the relationships in the 'innovation ecosystem': a biotech manager's perceptions of university-industry linkages
  • The influence of value proposition on supplier switching: a study of food ingredients
  • Reconciling stakeholder perspectives on freedom to operate review in research commercialisation, with case studies in biofuel from algae
  • A theoretical framework aiding in concept selection for new product development in waste stream
  • A cultural analysis of the consumer perceptions of functional foods promoting sleep
  • A study of science and industry collaboration: what makes a successful interaction?
  • New Zealand Business Management in the Agricultural Sector: a case study of factors influencing farmers' decisions in adopting novel technologies.
  • A comparative analysis of foreign markets for the international expansion of a New Zealand-based pharmaceutical firm
  • Developing a scorecard model for the ranking and selection of drug candidates
  • A study of the motivations and barriers for overseas Chinese investors to invest into New Zealand's life sciences
  • A study investigating the most effective intellectual property protection (IPP) methods to appropriate value from innovations based on natural sources, for small medium enterprises (SME's) in Australasia
  • Physician power over patient choice: what factors, physiological and psychological, play the biggest role in physician prescription choice in Parkinson's disease?
  • A cost-benefit analysis of GM High Energy ryegrass on the proposed agricultural emission trading scheme (ETS)
  • Capturing value from intellectual property: a study of the commercialisation of university based innovation
  • To collect or not to collect electronic medical data for business analytics, within a medical device organization
  • From disease to regulatory approval: a comparative case study of single product biomarker diagnostic companies' journeys
  • Using freedom to operate searches to develop commercialization strategy: a case study on a New Zealand medical device company
  • Understanding the various variables that are required in the project portfolio optimization from a technology transfer office (TTO) perspective
  • The process of developing a value proposition for radical innovation: a case study.


2009 Thesis topics:-

  • The birth and development of biotechnology clusters in Auckland – an analysis of the normative model
  • The nature of boards’ work: Strategising in the context of the converging pharmaceutical and consumer goods sectors in the New Zealand biotechnology industry
  • Demystifying the New Zealand public’s attitudes towards genetic engineering – An empirical analysis
  • Value creation and the role of collaborations, patents and licensing
  • Adoption of disruptive innovations in primary health care – A study of GPs and a gene test
  • The role of product modularity in the design of medical devices – A case study
  • New Zealand’s place in the biofuels world: A comparative analysis of potential feedstocks
  • Intellectual property capture in flavour biotechnology and flavoured products
  • Establishing a framework for competitive intelligence: A case study of a UN-NZ biotech start-up.


2008 Thesis topics:-

  • The influence of global health and well being trends in New Zealand upon consumers' desired value perceptions - A case study
  • The commercialisation of bioinformatics and market entry modes decision making: A case study from a New Zealand (……)firm
  • Evaluation criteria: comparison of biotechnology and high-technology sectors
  • Managing risk in new product portfolio decisions - a case study
  • Biotechnology business models and interfirm collaborations: A quantitative analysis
  • Achieving Fast Growth: Lessons for NZ biotech from NZs fastest growing companies since 2001
  • Successful strategies in botanical drug development companies (-Dynamic capabilities view)
  • Ingredient co-branding: strategic and marketing implications for a NZ supplier of functional ingredients
  • A decision support model for the strategic development of (‘x’ sector of the biotech industry)
  • Application of market opportunity analysis for pharmaceutical in-licensing decisions - a case study on x-drug and y-drug markets in country-Z.


2007 Thesis topics:-

  • Commercializing Medical Devices in China: An Investigation of the Current Regulatory Environment
  • The Impact of the New Zealand Venture Investment Fund (NZVIF) Investment Programmes on the New Zealand Biotechnology Industry
  • A Generalizable Model for Biotech Market Opportunity Assessment
  • Resource Allocation, Research Maturity and the Commercialisation Decision?
  • Strategic Alliance for New Zealand Biotech Start-ups – Product Commercialization
  • Identifying the potholes on the route to New Zealand Biotechnology Funding
  • What environment should New Zealand provide to attract foreign manufacturing?
  • Analysis of Business Models in the New Zealand Human Health Biotechnology Sector
  • Minimizing Time to Market via Early Consideration of Regulatory Affairs.